Thrivent Financial for Lutherans’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $950K | Hold |
67,917
| – | – | ﹤0.01% | 1806 |
|
|
2025
Q1 | $924K | Sell |
67,917
-25,055
| -27% | -$341K | ﹤0.01% | 1765 |
|
|
2024
Q4 | $1.9M | Sell |
92,972
-45,890
| -33% | -$935K | ﹤0.01% | 1474 |
|
|
2024
Q3 | $4.05M | Buy |
138,862
+8,358
| +6% | +$243K | 0.01% | 1025 |
|
|
2024
Q2 | $3.03M | Buy |
130,504
+65,729
| +101% | +$1.53M | 0.01% | 1125 |
|
|
2024
Q1 | $1.33M | Buy |
64,775
+35,093
| +118% | +$721K | ﹤0.01% | 1720 |
|
|
2023
Q4 | $637K | Buy |
+29,682
| New | +$637K | ﹤0.01% | 2118 |
|